Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 1996
View Archived Issues
Ethical's sustained-release morphine sublicensed for Canada
Read More
Antimicrobial peptide combinations available for licensing
Read More
Methods for screening for neurotoxicity offered for licensing
Read More
Frog peptides with antimicrobial activity available for licensing
Read More
Novel porphycene compounds synthesized at Cytopharm
Read More
Dual-action PDE IV/TNF-alpha inhibitors reported by Janssen
Read More
Lilly research into antiobesity proteins continues
Read More
Therapeutically active NPY analogues reported by Salk Institute
Read More
Antihyperlipidemic agents from natural source described by Takeda
Read More
Potent ACAT inhibitor discovered by Kitasato Institute
Read More
Antiproliferative agents disclosed by Kitasato Institute
Read More
New anxiolytic under development at Parke-Davis
Read More
Antiepileptic agent reported by Parke-Davis
Read More
Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity
Read More
Axcan-Schwarz joint venture to market URSO
Read More
Ivermectin approved for use in humans
Read More
SuperGen-Galenica anticancer drug collaboration
Read More
Expanded patent portfolio for Dyax technology
Read More
Lidak reacquires certain rights to Lidakol from BMS
Read More
Antiepileptic drug from Neurogen licensed to Wyeth-Ayerst
Read More
Patent issued for method of diagnosing and treating impotence
Read More
Incyte-Affymetrix to develop and commercialize new chip-based genomic databases
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe